Breaking News

Trials & Filings in Brief: Oct. 17, 2013

By Gil Roth | October 17, 2013

AltheRx, AMAG, Discovery Labs, EMD Serono, Pfizer, Relypsa, Savara, Vertex

Phase II
Relypsa HKL treatment reduces serum potassium . . . read more

Savara receives CFFT grant for inhaled antibiotic . . . read more

Phase III
Huge R&D update from Vertex . . . read more

Filings
AltheRx gets patent for OAB combination . . . read more

AMAG PDUFA date delayed . . . read more

Discovery Labs files IND for Aerosurf . . . read more

EMD Serono Gonal-F injector pen approved . . . read more

Pfizer get expanded Prevnar 13 label in EU . . . read more

blog comments powered by Disqus